Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2272 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Shanghai ChemPartner and SKK form alliance

The partnership was formed as a key element of a strategic initiative for Sanwa Kagaku Kenkyusho (SKK) to target the Asian market, in step with SKK’s new medium-long

ChemDiv Group acquires Prudentas

ChemDiv sees great potential in this acquisition by adding value to ChemDiv’s Discovery outSource services offered to pharmaceutical and biotech companies worldwide. Nikolay Savchuk, president and CEO of

Chiltern acquires Vigiun

Vigiun was previously established by Eduardo Forleo and Elisa Halker. Dr Forleo has been appointed Chiltern’s country manager for Brazil and medical director for Latin America. Ms Halker

Actavis reintroduces oxycodone in US

Oxycodone is reportedly the first product to be manufactured at Actavis’s Little Falls, New Jersey facility following a recently completed FDA inspection. In December 2008, Actavis has reached

MedLink signs agreement with Zwanger-Pesiri

Pursuant to the terms of the agreement, referring physicians of Zwanger-Pesiri will now be able to access images and reports through the MedLink EHR and MedLink EHR Lite.